483 related articles for article (PubMed ID: 4213330)
21. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
Bauernfeind A; Przyklenk B
Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
[No Abstract] [Full Text] [Related]
22. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs.
Hoiby N; Jacobsen L; Jorgensen BA; Lykkegaard E; Weeke B
Acta Paediatr Scand; 1974 Nov; 63(6):843-8. PubMed ID: 4215280
[No Abstract] [Full Text] [Related]
23. Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients.
Trancassini M; de Vito D; Cimino G; Antonelli M; Quattrucci S; Cipriani P
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):309-12. PubMed ID: 8781882
[TBL] [Abstract][Full Text] [Related]
24. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection.
Giordano A; Magni A; Filadoro F; Graziani C; Quattrucci S; Cipriani P
New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G; Shand GH; Fomsgaard A; Høiby N
APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
[TBL] [Abstract][Full Text] [Related]
26. Nitroblue-tetrazolium staining of human neutrophil granulocytes. Effects of stimulation with Pseudomonas antigens in the presence or absence of human Pseudomonas precipitins.
Koch C; Hoiby N
Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):787-94. PubMed ID: 4131384
[No Abstract] [Full Text] [Related]
27. Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients.
Cruz AC; Neves BC; Higa LY; Folescu T; Marques EA; Milagres LG
APMIS; 2012 Aug; 120(8):622-7. PubMed ID: 22779684
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
Hoiby N
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):541-50. PubMed ID: 4153350
[No Abstract] [Full Text] [Related]
29. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
30. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
[TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis respiratory infections: interactions between bacteria and host defence.
Döring G
Monaldi Arch Chest Dis; 1997 Aug; 52(4):363-6. PubMed ID: 9401367
[TBL] [Abstract][Full Text] [Related]
32. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis.
Govan JR; Harris GS
Microbiol Sci; 1986 Oct; 3(10):302-8. PubMed ID: 3155268
[TBL] [Abstract][Full Text] [Related]
33. [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].
Moss RB
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():42-6; discussion 47. PubMed ID: 8499750
[TBL] [Abstract][Full Text] [Related]
34. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
35. Antibodies against Pseudomonas aeruginosa in serum from normal persons and patients colonized with mucoid or non-mucoid Pseudomonas aeruginosa: Results obtained by crossed immunoelectrophoresis.
Holby N
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):142-8. PubMed ID: 404843
[TBL] [Abstract][Full Text] [Related]
36. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
[TBL] [Abstract][Full Text] [Related]
37. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
Winkler U; Wingender J; Jäger KE
Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
[TBL] [Abstract][Full Text] [Related]
38. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.
Douglas TA; Brennan S; Berry L; Winfield K; Wainwright CE; Grimwood K; Stick SM; Sly PD;
Thorax; 2010 Nov; 65(11):985-90. PubMed ID: 20889526
[TBL] [Abstract][Full Text] [Related]
39. Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.
Doggett RG; Harrison GM
Infect Immun; 1972 Oct; 6(4):628-35. PubMed ID: 4628901
[TBL] [Abstract][Full Text] [Related]
40. Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.
Banwart B; Splaingard ML; Farrell PM; Rock MJ; Havens PL; Moss J; Ehrmantraut ME; Frank DW; Barbieri JT
J Infect Dis; 2002 Jan; 185(2):269-70. PubMed ID: 11807706
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
